Evidence map›Paper›PMID 35228700›Full record

ArticleNature neuroscience2022

Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO).

Yuan Shi, Mochen Cui, Katharina Ochs, Matthias Brendel, Felix L Strübing, Nils Briel, Florian Eckenweber, Chengyu Zou, Richard B Banati, Guo-Jun Liu and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Use of Drugs Affecting GABAMolecular neurobiology · 2025
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Carvone derived cannabidiol enantiomers as novel anticonvulsants.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Sleep Abnormalities and Risk of Alzheimer's Disease.Current neurology and neuroscience reports · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 5 countries.

Yuan ShiCenter for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-6135-1830
Mochen CuiCenter for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany.
Katharina OchsCenter for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany.
Matthias BrendelDepartment of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilian University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-9247-2843
Felix L StrübingCenter for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-9436-6294
Nils BrielCenter for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-4349-3277
Florian EckenweberDepartment of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilian University of Munich, Munich, Germany.
Chengyu ZouCenter for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany.
Richard B BanatiAustralian Nuclear Science and Technology Organisation (ANSTO), Sydney NSW, Australia.ORCID http://orcid.org/0000-0003-3558-597X
Guo-Jun LiuAustralian Nuclear Science and Technology Organisation (ANSTO), Sydney NSW, Australia.ORCID http://orcid.org/0000-0002-4278-8372
Ryan J MiddletonAustralian Nuclear Science and Technology Organisation (ANSTO), Sydney NSW, Australia.
Rainer RupprechtDepartment of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Uwe RudolphDepartment of Comparative Biosciences, College of Veterinary Medicine, and Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.ORCID http://orcid.org/0000-0001-9396-4746
Hanns Ulrich ZeilhoferInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-6954-4629
Gerhard RammesDepartment of Anesthesiology and Intensive Care Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Jochen Herms *Center for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany. jochen.herms@dzne.de.ORCID http://orcid.org/0000-0002-6201-1042
Mario M Dorostkar *Center for Neuropathology, Ludwig Maximilian University of Munich, Munich, Germany. mario.dorostkar@med.uni-muenchen.de.ORCID http://orcid.org/0000-0001-8037-4907
German Center for Neurodegenerative Diseases · DELudwig-Maximilians-Universität München · DEThe University of Sydney · AUAustralian Nuclear Science and Technology Organisation · AUChinese Academy of Sciences · CNTUM Klinikum · DEUniversity of Illinois Urbana-Champaign · USUniversity of Regensburg · DEUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Benzodiazepines are widely administered drugs to treat anxiety and insomnia. In addition to tolerance development and abuse liability, their chronic use may cause cognitive impairment and increase the risk for dementia. However, the mechanism by which benzodiazepines might contribute to persistent cognitive decline remains unknown. Here we report that diazepam, a widely prescribed benzodiazepine, impairs the structural plasticity of dendritic spines, causing cognitive impairment in mice. Diazepam induces these deficits via the mitochondrial 18 kDa translocator protein (TSPO), rather than classical γ-aminobutyric acid type A receptors, which alters microglial morphology, and phagocytosis of synaptic material. Collectively, our findings demonstrate a mechanism by which TSPO ligands alter synaptic plasticity and, as a consequence, cause cognitive impairment.

Indexed as

DiazepamMicrogliaAnimalsBenzodiazepinesCognitionMiceMitochondrial ProteinsReceptors, GABABenzodiazepinesBzrp protein, mouseDiazepamMitochondrial ProteinsReceptors, GABA

Identifiers

PMID35228700
OpenAlexW4214538245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.